Evolve Medtech Partners

What Evolve Medtech Partners does

Evolve Medtech Partners is a privately held medical device development company and "discovery engine" headquartered in Solana Beach, California. Founded in 2018, the firm incubates, co-locates, and develops early-stage medical device companies in-house, providing inventors, physicians, and entrepreneurs with end-to-end capabilities spanning product development, intellectual property strategy, regulatory and quality systems, manufacturing, commercialization, clinical research, and business development. Its facility includes a wet lab, R&D workspace, and advanced prototyping equipment, and its operations run under an ISO 13485:2016 and 21 CFR 820 compliant quality management system.

The current portfolio spans nine companies across cardiovascular, neurovascular, electrophysiology, and orthopedic indications, including catheter-based vascular access systems (Cross Vascular, Vector Vascular, ClearPath Vascular), pulsed field ablation technology (Arga Medtech), wireless battery-less atrial fibrillation devices (Maxwell Biomedical), single-use surgical retractors (Retractor Ortho), and transseptal access platforms (Single-Pass). Engineering capabilities cover rapid prototyping, laser cutting and bonding, CNC machining, ultrasonic welding, process development, FEA, materials science, and design-for-manufacturing. The IP base across the four partners exceeds 106 issued U.S. patents, and partner Gerard von Hoffmann has led IP diligence on venture financings valued above $1.6 billion and acquisitions and IPOs valued above $3.8 billion.

Economically, the firm operates as both a services provider and a portfolio investor, generating value through development fees, equity participation, and liquidity events. Three portfolio companies have been acquired by strategics: Traverse Vascular by Teleflex in June 2022, Single-Pass by Circa Scientific in December 2023, and Boa Medical by a strategic medical device company in April 2025. Pricing and revenue are not publicly disclosed. Geographic operations are concentrated in North County San Diego, with strategic co-investment via E-merge Capital Partners and channel relationships with MMC Medical and Pathway Medtech.

Name

Evolve Medtech Partners

Legal name

Evolve Medtech Partners

Website

https://evolve-medtech.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Evolve Medtech Partners is a private medical device development company and portfolio operator that incubates, co-locates, and advances early-stage medtech ventures from concept through commercialization or strategic exit. Based in Solana Beach, California.

Ownership category

akta.pro rank

Product category

Medical Device Development Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAIALAF

Translational Medicine & Biomarkers

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

• Medical device development
• Medical device incubation
• Regulatory affairs services
• Intellectual property strategy
• Clinical research services

Headquarters

HQ city

Solana Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels1 record

Marketing channels2 records

Core offering

Evolve Medtech Partners is a medical device development company and discovery engine that collaborates with inventors, physicians, companies, and investors to advance medical device ideas from conception through licensing, acquisition, or commercialization. The company operates an ISO 13485:2016 and 21 CFR 820 compliant quality management system and provides end-to-end capabilities in product development, intellectual property strategy, regulatory and quality, manufacturing, commercialization, clinical research, and business development, supporting a portfolio of early-stage medical device businesses co-located within its Solana Beach facility.

Product overview

Evolve Medtech Partners is a medical device development company and discovery engine that operates as a portfolio of early-stage medical device companies. The company collaborates with inventors, physicians, companies, and investors to advance ideas from conception through licensing, acquisition, or commercialization. Its portfolio includes both independently operated portfolio companies (Cross Vascular, Arga Medtech, Maxwell Biomedical, Retractor Ortho, Vector Vascular, ClearPath Vascular) and acquired companies (Traverse Vascular acquired by Teleflex, Single-Pass acquired by Circa Scientific, Boa Medical acquired April 2025). The company provides leadership and expertise across product development, intellectual property strategy, regulatory and quality, manufacturing, commercialization, clinical and business development, operating an ISO 13485:2016 compliant quality management system.

Differentiator

Problem solved

Functional benefit

Products and services

• Cross Vascular Patented RF transseptal access system that improves upon a widely accepted transseptal approach while maintaining current physician workflow, developed for electrophysiology and structural heart procedures.
• Arga Medtech Next-generation non-thermal cardiac ablation system pairing a unique Pulsed Field Ablation generator with a proprietary catheter for cardiac ablation procedures.
• Maxwell Biomedical Pain-free, wireless, and battery-less medical device for the treatment of atrial fibrillation (Afib).
• Retractor Ortho Single-use surgical retractor technology designed to improve surgeon visualization and workflow during orthopedic surgical procedures.
• Vector Vascular Catheter-based technology intended to assist in venous stenting procedures.
• ClearPath Vascular Advanced neuro and peripheral vascular access solutions designed to optimize procedural efficiency and safety.
• Medical Device Development and Discovery Engine Services End-to-end medical device development and discovery engine services for inventors, physicians, early-stage companies, and investors, including opportunity assessment, product development, IP strategy, regulatory and quality support, manufacturing, commercialization, clinical, and business development.

Quantifiable outcome

• Multiple successful exits including Traverse Vascular (acquired by Teleflex, June 2022), Single Pass (acquired by Circa Scientific, December 2023), and Boa Medical (acquired, April 2025)
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor.

• MMC MedicalminorChannel Partner/ Reseller/ DistributorMedical device distribution partner providing channel access for medical device products.
• Pathway MedtechminorStrategic or Co-development PartnerStrategic partnership in the medical device ecosystem supporting innovation and commercialization.

Scale indicators3 records

Expansion highlights5 records

Direct peers

• Coridea: Medical device incubator founded by serial medtech entrepreneur Howard Levin that conceives, develops, and spins out device companies. Closely matches Evolve's co-located, multi-portfolio approach to building cardiovascular and adjacent device companies.
• Fogarty Innovation: Nonprofit medical device incubator located on the El Camino Health campus that supports physician-innovators through prototyping, regulatory, and commercialization. Directly comparable as a co-located medtech incubator serving inventors and physicians.
• InCube Labs: Multi-program medical device incubator founded by Mir Imran that takes concepts from idea through clinical milestones and exit. Operates a similar discovery-to-exit engine across multiple therapeutic areas, making it the closest analog to Evolve Medtech's model.
• MEDX Ventures Group: Medtech-focused venture and incubation firm that builds and funds early-stage device companies across cardiovascular and other specialties. Comparable as a partner-led incubator combining operational support with venture capital.

Broad incumbents

• Battelle Memorial Institute: Large nonprofit R&D organization with life sciences and medical device programs that operates similar discovery-to-commercialization pipelines. Comparable in underlying R&D services capability but at vastly larger scale and scope than Evolve.
• SRI International: Independent nonprofit R&D organization that creates and spins out technology ventures, including medical devices. Comparable as a much larger, broader R&D and venture-creation platform with overlapping capabilities in prototyping, IP, and regulatory support.
• Johnson & Johnson Innovation (JLABS): Strategic-acquirer-backed no-strings-attached incubator network providing lab space, prototyping, and regulatory support to early-stage medical device and biotech companies. Comparable as a co-located incubator serving the same inventor/early-stage customer segment.

Emerging players

• ExploraMed: Medical device incubator founded by Josh Makower that incubated companies ultimately acquired by J&J/Ethicon. Comparable as a multi-program medtech incubator with an exit-oriented model, though now largely folded into a strategic acquirer's pipeline.
• Springboard Enterprises: Venture catalyst that supports and accelerates growth-stage life sciences and healthcare companies through curated programs and investor introductions. Comparable as a portfolio support platform for emerging healthcare ventures, though less device-incubation focused.

Others

• E-merge Capital Partners: Early-stage life sciences venture capital fund whose Managing Partner is also Evolve's Managing Partner. Comparable as a directly aligned capital partner that co-invests in Evolve's portfolio companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/evolve-medtech-partners

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evolve Medtech Partners